Introduction {#sec1}
============

VARP (VPS9-domain ankyrin repeat protein) is a widely expressed, multidomain protein of 1,050 residues present in most animals (although lost from *D. melanogaster* and *C. elegans*), as well as in some species of unicellular organisms closely related to animals, including Capsaspora and Choanoflagellates. VARP is a Rab32/38 effector, and, in line with other Rab:Rab-effector systems, it has been assumed that Rab32 would be primarily responsible for recruiting VARP on to membranes ([@bib60; @bib63]). VARP also possesses Rab21 GEF (guanine nucleotide exchange factor) activity ([@bib67]) and binds to VAMP7 ([Figure 1](#fig1){ref-type="fig"}A), an R-SNARE implicated in a variety of endocytic and exocytic fusion events ([@bib3; @bib17; @bib36; @bib37; @bib45; @bib47]) (reviewed in [@bib9]). VARP binds to VAMP7 in its "closed," prefusion conformation, and this interaction inhibits VAMP7-mediated SNARE complex formation by clamping its regulatory longin domain on to its SNARE motif ([@bib50]). Through associations with GolginA4 and Kif5A, VARP has also been suggested to participate in a molecular network that regulates delivery of VAMP7-containing vesicles toward the cell periphery ([@bib7]), which could contribute to the process of neurite outgrowth ([@bib6]).

The Rab family of small GTPases plays a key role in protein sorting and membrane trafficking throughout eukaryotic cells (reviewed in [@bib58]). Rab32 is an endosomal Rab GTPase, thought to have been present in the last eukaryotic common ancestor, with Rab38 arising in vertebrates as an evolutionary gene duplication of Rab32 ([@bib30]). Rab32 (together with Rab7A and B, Rab7L1, Rab9A and B, and Rab23) is classified in the late endocytic group III Rabs ([@bib30]), a group of Rabs with functions at multiple points along the endocytic system. For example, Rab7A mediates the recruitment of the retromer complex ([@bib49; @bib55]) and is also important for delivery to lysosomes (reviewed in [@bib58]).

Rab32 is expressed in a variety of cell types ([@bib12]) and has been implicated in the biogenesis of, and transport to, lysosome-related organelles (LROs) such as melanosomes ([@bib5; @bib42; @bib60; @bib65]), autophagosomes ([@bib64]), and platelet dense granules ([@bib1]). Rab38 is expressed in specialized cell types enriched in LROs ([@bib40]) and serves partially redundant functions with Rab32. Consistent with VARP functioning as a Rab32/38 effector, in melanocytes, VARP colocalizes with Rab32/38 on endocytic organelles and melanosomes ([@bib65]). In other cell types, VARP localizes primarily to endosomes but is also present on vesicular/tubular clusters, lysosomes, and the plasma membrane ([@bib50]), a pattern of localization consistent with VARP's multiple functions.

We set out to determine the molecular mechanism of the expected recruitment of VARP to endosomal membranes by Rab32/Rab38. We determined the crystal structure of the complex between the first ankyrin repeat domain of VARP with the GTP hydrolysis-deficient forms of Rab32 and Rab38. Unexpectedly, however, we found that mutations based on these structures, which abolished their interaction in vitro, did not prevent endosomal recruitment of VARP in vivo. Subsequently, we have identified the retromer subunit VPS29 as a direct binding partner of VARP. Precise mapping of the VPS29-VARP interaction shows this interaction recruits VARP on to endosomes, and we demonstrate that VARP, retromer, and VAMP7 operate together in a pathway that traffics the known retromer cargo GLUT1 from endosomes to the cell surface.

Results {#sec2}
=======

Structure of the VARP Ankyrin Repeat-Containing Domain:Rab32 Complex {#sec2.1}
--------------------------------------------------------------------

VARP has been shown to interact with Rab32/38 via its first ankyrin repeat-containing domain ([@bib60; @bib61; @bib63]). Two fragments of VARP comprising residues 397--650 and 451--640 of VARP, which contains the first ankyrin repeat-containing domain (ANKRD1; [Figure 1](#fig1){ref-type="fig"}A), bind to Rab32 in a GTP-dependent manner with a dissociation constant, K~D~, of 7 ± 3 μM and a K~D~ of 2.5 ± 0.4 μM, respectively ([Figure 2](#fig2){ref-type="fig"} and [Figure S1](#app3){ref-type="sec"}A available online). We were able to crystallize a 1:1 complex of the smaller VARP fragment (residues 451--640) with the GTP hydrolysis-defective mutant of Rab32 (Q85L) in the presence of the nonhydrolyzable analog of GTP, GppCp. Its structure was solved at 2.8Å resolution by molecular replacement using VARP ANKRD2 and Rab7:GTP as search models ([Figure 1](#fig1){ref-type="fig"}B; [Table 1](#tbl1){ref-type="table"}). The final model comprises three molecules of the complex in the asymmetric unit, where VARP (residues 452--618), Rab32 (residues 22--198), and Rab32's bound GppCp:Mg^2+^ are well defined in the electron density map ([Figures S1](#app3){ref-type="sec"}C and S1D). The three complexes in the asymmetric unit all have the same structure, with root-mean-square deviation (rmsd) values of 0.32 Å (for 306 Cα atoms of molecules A and B) and 0.33 Å (for 313 Cα atoms of molecules A and C).

VARP ANKRD1 contains five tandem ankyrin repeats that form a slightly curved stack ([Figure 1](#fig1){ref-type="fig"}B). The structure of Rab32 bound to GppCp:Mg^2+^ resembles that of other effector-bound Rabs (reviewed in [@bib32]). The P loop (residues 32--39) stabilizes the Mg^2+^-coordinated triphosphate moiety of the nucleotide, while Switch-I (residues 48--61) folds over the nucleotide molecule and stabilizes the γ-phosphate of the GppCp. Switch-II (residues 84--97) also stabilizes the γ-phosphate but differs somewhat in conformation as compared to those in other GTP-bound Rab structures ([Figure S1](#app3){ref-type="sec"}B).

The VARP ANKRD1:Rab32 heterodimer buries 1,530 Å^2^ of solvent accessible surface area (calculated with PISA; [@bib31]) ([Figure 1](#fig1){ref-type="fig"}D). The elongated interface consists of a central hydrophobic patch of residues from helices α2B (L513 and L514) and α3B (Y550 and Y551) of VARP and residues from Switch-I (V60), interswitch (F62, L69, and W80), and Switch-II (M91, V94, K97, and Y95) of Rab32. Flanking the hydrophobic core of the interface are two salt bridges formed through Switch-II of Rab32 (D480^VARP^-R93^Rab32^, H517^VARP^-K97^Rab32^) and a third one through the interswitch of the GTPase (K546^VARP^-D61^Rab32^). The residues involved in these interactions are conserved in other organisms ([Figure 1](#fig1){ref-type="fig"}E). Many of the key interacting residues in Rab32 are unique to Rab32/38, thus explaining the selectivity for VARP binding Rab32/38 over other endosomal Rabs, as demonstrated in "glutathione S-transferase (GST) pull-down" experiments ([Figure S1](#app3){ref-type="sec"}E).

Interactions between the Switch-I/interswitch/Switch-II regions of Rab GTPases usually occur with two long α helices of an effector, which are often antiparallel and connected by a tight turn ([Figure S2](#app3){ref-type="sec"}A). However, although also displaying a similar low micromolar K~D~ interaction to other Rab:Rab-effector interactions ([@bib58]), the Rab-binding region of VARP is formed by residues from four short parallel α helices, making this an unexpected mechanism of Rab:Rab-effector binding. Most stacked ankyrin-repeat domains bind their partners on their concave side, whereas our results show that the interaction occurs on the convex side of the stack and, thus, leaving the concave side available to potentially bind other VARP interactors.

Mutational Analysis of the VARP-ANKRD1:Rab32 Complex Interface {#sec2.2}
--------------------------------------------------------------

Four residues within VARP that contribute to the complex interface, L513^VARP^, Y550^VARP^, Q509^VARP^, and K546^VARP^ were mutated, and their ability to bind Rab32 in its GTP-locked state in solution was investigated (note that Q509^VARP^ and Y550^VARP^ have been previously proposed to participate in the VARP:Rab32/38 interaction; [@bib61]). Two double mutants, Q509A/Y550A and L513D/K546D, were also generated. The results of GST pull-down assays ([Figure 2](#fig2){ref-type="fig"}C) showed that VARP (wild-type \[WT\]) binds GSTRab32(Q85L) but not GST. VARP(Y550A) and VARP(K546D) showed reduced binding to GSTRab32:GTP, while the mutants Q509A, L513D, L513D/K546D, and Q509A/Y550A showed no detectable binding ([Figure 2](#fig2){ref-type="fig"}C). In broad agreement with these data, subsequent isothermal titration microcalorimetry (ITC) showed that the K~D~s for the interaction of these mutants were increased from 2.5 μM for WT VARP451-640 to ∼8 μM for K546D, ∼22 μM for Y550A, and ∼30 μM for Q509A ([Figure 2](#fig2){ref-type="fig"}B). The L513D mutation reduced binding to below detectable levels (K~D~ \> 300 μM), as did the double mutant Q509A/Y550A, but the L513D/K546D mutant was unstable in the constantly stirring environment of the ITC cell.

Mutating residues M91/R93 in Switch-II of Rab32, which participate in the interaction with VARP ([Figure 2](#fig2){ref-type="fig"}D), resulted in reduced binding as shown by pull down ([Figure 2](#fig2){ref-type="fig"}F) and no detectable binding by ITC ([Figure 2](#fig2){ref-type="fig"}E).

Dimerization of the Rab32:VARP Heterodimer {#sec2.3}
------------------------------------------

Many small GTPase:effector complexes are believed to form dimers, which increases both the apparent affinity and specificity of the recruitment of effectors to membrane-anchored GTPases ([@bib32; @bib41]). In the crystal, all VARP:Rab32 heterodimers form identical homodimers, resulting in the heterotetramers shown in [Figures 1](#fig1){ref-type="fig"}C and 1D. The majority of the heterodimer/heterodimer interface arises from the VARP molecules contacting the other Rab32 molecule in the tetramer through residues from Switch-I and Switch-II that are different from those involved in the VARP:Rab32 heterodimer formation. This second VARP:Rab32 interface buries 1,460 Å^2^ of solvent accessible surface area, making the total solvent accessible buried surface area on tetramer formation around 6,400Å^2^, which suggests that the tetramer should be stable. Existence of a dimer of heterodimers in solution is supported by analytical gel filtration, which is consistent with the existence of a concentration-dependent equilibrium of a 2:2 tetramer and a 1:1 heterotetramer in solution ([Figures S2](#app3){ref-type="sec"}B and S2C). Further evidence comes from size exclusion chromatography with multiangle light scattering (data not shown), as well as the observation that, in crystals, VARP ANKRD1:SeMet-Rab32Q85L and VARP ANKRD1:Rab38Q69L contain the same "cross-dimer of heterodimers" across multiple crystal forms, as compared to the wtVARP:Rab32Q85L complex ([Tables 1](#tbl1){ref-type="table"} and [S1](#app3){ref-type="sec"}).

VARP Recruitment to Endosomes Does Not Depend on Binding to Rab32/38 and/or VAMP7 {#sec2.4}
---------------------------------------------------------------------------------

It is generally accepted that most Rab effectors are recruited to their respective sites of action through binding to their cognate Rab (reviewed in [@bib58]). Furthermore, taking into account the published literature and conceptual similarities to other Rab:Rab-effector interactions (such as binding to GTP-bound Rab only and Rab-induced dimerization), we anticipated that VARP endosomal recruitment would be Rab32/38 dependent. However, when stably expressed in HeLa cells, the Rab32/38 binding-deficient mutant versions of VARP-green fluorescent protein (GFP) (Q509A/Y550A and L513D/K546D) localized to punctate endosomal structures in a manner similar to that of WT VARP ([Figures 2](#fig2){ref-type="fig"}G and [S2](#app3){ref-type="sec"}D). We further tested the possibility that VAMP7 could also be involved in VARP recruitment, but we observed that stably expressed mutant forms of VARP-GFP that cannot bind to VAMP7 (M684D/Y687S), or to Rab32/38 and VAMP7 simultaneously (Q509A/Y550A/M684D/Y687S), remained localized to endosomes. These data led us to conclude that the initial recruitment of VARP to endosomes is not dependent on its binding to either Rab32/38 or VAMP7 but must be dependent on another membrane-associated protein or a membrane component that interacted with VARP, which we set out to identify. Because we found that VARP recruitment to endosomes was not dependent on Rab32, we felt that further investigation of the exact function of this GTPase fell outside the scope of the present study.

VARP Is Recruited to Endosomes by Retromer {#sec2.5}
------------------------------------------

In separate experiments, it had been observed that native immunoprecipitation of VPS29-GFP or GFP-VPS35 followed by mass spectrometry identified VARP as a potential interacting partner of retromer ([Figure S3](#app3){ref-type="sec"}A), in addition to established retromer accessory proteins, e.g., the WASH complex and the RabGAP TBC1D5 ([@bib24; @bib55]). Although far fewer VARP peptides than TBC1D5 and WASH complex peptides were isolated in these screening studies, the endosomal localization and central role in endocytic trafficking of retromer led us to consider it as a candidate for the role of recruiting VARP on to endosomes. In HeLa cells stably expressing VARP-GFP, small interfering RNA (siRNA)-mediated depletion of the retromer subunits VPS29 or VPS35, but not of Rab32 or VAMP7, resulted in loss of VARP-GFP but not of EEA1 recruitment to endosomes ([Figures 3](#fig3){ref-type="fig"}A and 3B; [Figures S3](#app3){ref-type="sec"}B--S3D).

We next examined the subcellular colocalization of stably expressed VARP-GFP and the endogenous retromer and WASH complexes by immunofluorescence (IF) confocal microscopy. WT-VARP-GFP exhibited robust colocalization with the endogenous retromer subunit VPS26 on both vacuolar and tubular domains of endosomes ([Figures 3](#fig3){ref-type="fig"}C and 3D). The WASH complex subunit FAM21 ([@bib25]) colocalized with VARP and retromer on vacuolar domains of endosomes but was largely excluded from tubules ([Figures 3](#fig3){ref-type="fig"}C and [S3](#app3){ref-type="sec"}E) ([@bib25]). The Rab5 effector EEA1 appeared to localize in many instances to the same endosomes as VARP, although it was differentially partitioned on those structures when compared with VARP, which colocalizes with retromer and the WASH complex ([Figures 3](#fig3){ref-type="fig"}A, 3C, and [S3](#app3){ref-type="sec"}F).

Identification and Characterization of the VARP:VPS29 Interaction {#sec2.6}
-----------------------------------------------------------------

We used a combination of yeast 2-hybrid (Y2H) analysis, GST pull-downs with bacterially expressed proteins, and in vivo siRNA knockdown and rescue experiments to identify the retromer subunit VPS29 as the direct binding partner of VARP. By Y2H, strains expressing both VARP and VPS29 exhibited growth, but no growth was observed when VARP was coexpressed with retromer subunits VPS26A, VPS26B, or VPS35 ([Figure 4](#fig4){ref-type="fig"}A). In agreement with these data, in GST pull-downs, full-length VARP bound to GST-VPS29 and a retromer subcomplex containing GST-VPS35, VPS26, and VPS29 with near-1:1 stoichiometry but not to a retromer subcomplex of GST-VPS35 and VPS26 ([Figure 4](#fig4){ref-type="fig"}B). The interaction was further mapped, using fully folded ([@bib13]) mutant versions of VPS29 in both Y2H analysis and GST pull-downs, to a hydrophobic patch on the surface of VPS29, centered on Leu152 ([Figures 4](#fig4){ref-type="fig"}A, 4C, and [S4](#app3){ref-type="sec"}A), which also binds to the RabGAP TBC1D5 ([@bib24]) and, possibly, very weakly to Snx1 ([@bib13; @bib59]). In HeLa cells, endogenous VARP was coimmunoprecipitated with stably expressed WT-VPS29-GFP but not with L152E-VPS29-GFP ([Figure S4](#app3){ref-type="sec"}B). In vivo, the loss of endosomal recruitment of VARP-GFP following VPS29 depletion was rescued by expression of an siRNA-resistant form of VPS29-TagRFP (red fluorescent protein) ([Figures 4](#fig4){ref-type="fig"}D and [S4](#app3){ref-type="sec"}C). Consistent with the Y2H and biochemical interaction data, recruitment of VARP-GFP (or TBC1D5; [Figures 4](#fig4){ref-type="fig"}E and [S4](#app3){ref-type="sec"}D) was not rescued on expression of the L152E-VPS29 mutant. The specificity of this effect was demonstrated by the fact that FAM21 localization, which was also lost from endosomes on VPS29 depletion due to destabilization of the retromer complex ([Figure S4](#app3){ref-type="sec"}D), was rescued by both WT and L152E forms of VPS29 ([Figure 4](#fig4){ref-type="fig"}E), since FAM21 associates with retromer by binding to VPS35 ([@bib25; @bib26; @bib27]). Furthermore, the endosomal recruitment of EEA1 was not disrupted upon VPS29 depletion, indicating that VPS29 depletion does not simply disrupt overall endosomal integrity ([Figure 3](#fig3){ref-type="fig"}A; [Figures S3](#app3){ref-type="sec"}B and S3D). Thus, we conclude that VARP is recruited to endosomes through direct interaction with VPS29.

VPS29 Interacts with Two Cysteine-Rich Motifs within VARP {#sec2.7}
---------------------------------------------------------

The evolution of VARP appears to have involved tandem duplication of a region containing six ankyrin repeats. Two regions of VARP (residues 410--450 and 692--730), which separate the first two ankyrin repeats, each contain a cysteine-rich consensus motif with the sequence CHPLCxCxxC that is conserved across all species ([Figure 5](#fig5){ref-type="fig"}A). Each region was shown independently to bind directly to VPS29 by Y2H ([Figure 5](#fig5){ref-type="fig"}C). Indeed, in ITC experiments, recombinant VARP fragments containing the Cys-rich motifs (residues 396--460 and 692--746) in isolation were able to bind to VPS29 with K~D~s in the low micromolar range (∼13 μM and ∼5 μM, respectively; [Figure S5](#app3){ref-type="sec"}A).

The presence of a spatially conserved pattern of cysteines in an intracellular protein suggests the involvement of a metal: most likely, zinc. Consequently, elemental analysis by microbeam proton-induced X-ray emission (microPIXE) ([@bib20]) was carried out on both bacterially expressed domains to investigate this possibility. The resulting data ([Figure 5](#fig5){ref-type="fig"}B and [Table S2](#app3){ref-type="sec"}) indicate stoichiometric levels of Zn^2+^ in both Cys-rich motifs and that no other nonorganic elements are present at levels above 0.02 atoms per motif. Attempts to abrogate the interaction between VARP and VPS29 in vitro by adding EDTA in an effort to chelate the bound Zn^2+^ failed, presumably because of the difficulty of extracting tightly bound Zn^2+^, as has been previously observed for other "double Zn-finger"-containing proteins (J. Deane, personal communication).

Mutation of all four Cys residues to Ser (4C1 or 4C2), or of the conserved His and Leu residues to Ser and Ala (HL1 or HL2), in the context of ∼40-residue fragments containing the first or the second Cys-rich motifs, respectively, abolished binding to VPS29 by Y2H ([Figure 5](#fig5){ref-type="fig"}C). In ITC experiments using similar fragments, the HL2 mutation reduced binding to undetectable levels, while the 4C2 mutation decreased binding by ∼20-fold ([Figure S5](#app3){ref-type="sec"}A). In the context of full-length VARP, the HL1 and HL2 mutations reduced binding to VPS29 to below-detectable levels by Y2H ([Figure 5](#fig5){ref-type="fig"}C). However, in GST pull-downs, only simultaneous mutation of both HL1 and HL2 fully abolished VARP binding to VPS29 ([Figure 5](#fig5){ref-type="fig"}D). This agrees with data from HeLa cells stably expressing VARP-GFP, where extraction of non-membrane-associated proteins by a brief saponin wash prior to fixation resulted in only a partial loss of VARP-GFP from endosomes upon mutation of individual Cys-rich motifs, whereas simultaneous mutation of both motifs led to complete loss of VARP-GFP from endosomes ([Figure 5](#fig5){ref-type="fig"}E). This is in contrast to the effect of simultaneously mutating Rab32 and VAMP7 binding sites within VARP ([Figure 2](#fig2){ref-type="fig"}G). When these data are considered along with the small size of the VPS29 hydrophobic patch centered on L152 ([Figure S4](#app3){ref-type="sec"}), the relative band intensities in [Figures 4](#fig4){ref-type="fig"}B and [5](#fig5){ref-type="fig"}D, and the observation that a single Cys-rich motif binds to VPS29 with low micromolar K~D~ affinity ([Figure S5](#app3){ref-type="sec"}), the most likely scenario for the interaction between full-length VARP and VPS29 is a 1:1 stoichiometry with only one Cys-rich motif binding at any one time, with a resulting apparent K~D~ in the high nanomolar range. In other words, binding is relatively strong because of the presence of two binding sites for VPS29 on the same VARP molecule. Unfortunately, neither the K~D~ nor the stoichiometry of the binding of full-length proteins could be accurately determined, as all constructs containing both stacks of ankyrin repeats aggregated in ITC experiments, and all cocrystallization attempts have failed.

We therefore conclude that VARP is recruited on to endosomes through the direct interaction of its Cys-rich motifs with VPS29, thus placing its ability to bind and regulate the fusogenic potential of free VAMP7, and to interact with Rab32:GTP, on the surface of endosomes. In agreement with this model, GST pull-down experiments ([Figure 5](#fig5){ref-type="fig"}F) showed that VARP simultaneously binds to VPS29, Rab32/38, and VAMP7 in vitro.

A VARP/Retromer/VAMP7-Dependent Pathway Plays a Role in GLUT1 Traffic out of Endosomes {#sec2.8}
--------------------------------------------------------------------------------------

Recent studies have suggested that a number of cell surface receptors and transporters recycle from endosomes to the plasma membrane by a retromer-dependent pathway ([@bib43; @bib57; @bib62]). In light of our results showing that VARP associates with retromer, we hypothesized that depleting VARP and/or VAMP7 (which cycles from endosomes/endolysosomes through the plasma membrane \[[@bib46]\] and binds directly to VARP) should also disrupt the trafficking of retromer-dependent cargoes. We chose to analyze the recently characterized retromer cargo GLUT1, which redistributes from a predominantly cell surface localization to an intracellular endosomal localization upon retromer depletion ([@bib43; @bib57]). Consistent with these published findings, depletion of VPS29 in HeLa cells caused an increased intracellular distribution of GLUT1 as compared to control cells ([Figure 6](#fig6){ref-type="fig"}A; [Figure S6](#app3){ref-type="sec"}A). A similar redistribution of GLUT1 was also observed upon knockdown of VARP and VAMP7, whereas knockdown of the clathrin adaptor AP-1 had no effect on GLUT1 distribution. We followed up on these initial observations of GLUT1 redistribution by measuring the colocalization of GLUT1 with the late endosomal/lysosomal membrane protein LAMP1, because [@bib57] had previously shown that depletion of the retromer subunit VPS35 increased such colocalization. We observed a marked increase in the colocalization of GLUT1 with LAMP1 after knockdown of VPS29, VARP, or VAMP7 ([Figures 6](#fig6){ref-type="fig"}B and 6C; [Figures S6](#app3){ref-type="sec"}B and S6C) but, interestingly, not after depletion of the RabGAP TBC1D5 ([Figures S6](#app3){ref-type="sec"}B and S6D) that binds to VPS29 at the same site as VARP ([@bib24]). Subsequent experiments with transiently transfected HeLa cells showed that siRNA-resistant WT VPS29-TagRFP, but not the L152E mutant that does not bind VARP, was able to rescue the increase in colocalization of GLUT1 with LAMP1 observed after knockdown of endogenous VPS29 ([Figures 6](#fig6){ref-type="fig"}D, 6E, and [S6](#app3){ref-type="sec"}E). There was no statistically significant difference in colocalization of GLUT1 with LAMP1 after knockdown of VPS29 in cells expressing the siRNA-resistant L152E mutant when compared with nearby untransfected cells ([Figures 6](#fig6){ref-type="fig"}D and [S6](#app3){ref-type="sec"}E). These data confirmed that the interaction between VARP and VPS29 was necessary to rescue the GLUT1/LAMP1 colocalization phenotype observed after knockdown of VPS29.

Taken together, our data demonstrate that VARP and VAMP7 act within the retromer-dependent recycling pathway that traffics the glucose transporter GLUT1 from endosomes to the plasma membrane. Our rescue experiments show that the VPS29 requirement for this pathway is dependent on its binding to VARP. Given the role of retromer in mediating traffic out of endosomes, and the knowledge that VARP binds the retromer subunit VPS29 and VAMP7 at different binding sites, we decided to study further whether the intracellular distribution of VAMP7 is affected by its association with VARP/retromer. Stable HeLa cell lines expressing WT VAMP7-HA or the D69A, E71F, S73D (DES) mutant VAMP7-HA, which we have previously shown cannot bind VARP ([@bib50; @bib28]), were examined by IF confocal microscopy. The DES VAMP7-HA mutant was primarily distributed to the perinuclear region as compared to WT VAMP7-HA, which had a more peripheral endosomal localization in addition to a perinuclear pool ([Figure 7](#fig7){ref-type="fig"}A). This difference in localization was quantified by measuring the degree of colocalization between VAMP7-HA and the trans-Golgi network (TGN) marker TGN46, with DES VAMP7-HA exhibiting a higher degree of colocalization ([Figure 7](#fig7){ref-type="fig"}B). The increased colocalization of DES VAMP7-HA with TGN46 was lost on treatment of the cells with chloroquine (CQ), which inhibits the trafficking of proteins from endosomes to the TGN ([@bib10; @bib28; @bib48]) but only weakly affects the distribution of TGN46 ([@bib44]), unlike the more marked effect on its ortholog TGN38 in rodent cells ([@bib10]). Our data with the DES mutant of VAMP7 imply that the normal cycling of VAMP7 within the endocytic sytem is dependent on its interaction with VARP, in addition to its interactions with Hrb ([@bib46]) and AP3-Δ-adaptin ([@bib28]). We also observed an increase in colocalization of WT VAMP7-HA with TGN46 after knocking down the retromer subunits VPS29 or VPS35 ([Figures 7](#fig7){ref-type="fig"}C and 7D).

Discussion {#sec3}
==========

Retromer drives trafficking from endosomes/endolysosomes via tubular-vesicular carriers to either the Golgi or the cell surface ([@bib15; @bib52; @bib56]). Here, we have shown that VARP is recruited to endosomes through a direct interaction with retromer, where it participates in the retromer-dependent pathway that delivers the glucose transporter GLUT1 to the plasma membrane ([Figures 7](#fig7){ref-type="fig"}C and 7D).

The current working model for retromer function suggests that, in mammalian cells, the VPS26/35/29 subcomplex associates with endosomal membranes via Rab7A ([@bib49; @bib55]) and Snx3 (reviewed in [@bib15; @bib52]). Cargo selective functions have been suggested for VPS26 ([@bib19]), VPS35 ([@bib2; @bib38; @bib51]), and the associated sorting nexin, Snx27 ([@bib22; @bib57; @bib62]). Retromer also interacts with the WASH complex, which promotes localized actin polymerization to provide a structural and/or force-generating scaffold on which endosomal tubular carriers may be formed ([@bib16; @bib23; @bib24; @bib27]). The known destinations of retromer-derived carriers leaving endosomes are the Golgi and the cell surface ([@bib15; @bib19; @bib51; @bib52; @bib57; @bib62]). The interaction between retromer and VARP described here places VARP firmly in the trafficking pathway from endosomes to the cell surface and further cements the role of retromer as a hub for recruiting key machinery required for trafficking out of endosomes ([@bib24]) ([Figure 7](#fig7){ref-type="fig"}C). The binding of VARP by retromer is mediated by the VPS29 subunit and involves the same cluster of hydrophobic residues that mediates the association of retromer with the RabGAP TBC1D5. It has been proposed that binding of TBC1D5 by retromer leads to retromer dissociation from membranes through increasing GTP hydrolysis of Rab7A, a Rab key to retromer recruitment ([@bib24; @bib55]) VARP association with retromer may inhibit the binding of TBC1D5, leading to a more persistent association of retromer with the membrane, thereby facilitating the sorting of cargo proteins into the endosome-to-cell surface pathway. Retromer was first identified in yeast ([@bib53; @bib54]) and was shown to mediate endosome-to-Golgi retrieval. To date, there is no compelling evidence that retromer in yeast can drive endosome-to-cell surface traffic, and VARP is not present in yeast, consistent with the hypothesis that VARP regulates the activity of retromer in the endosome-to-cell surface pathway in mammalian cells ([@bib21; @bib29; @bib39; @bib49; @bib55; @bib58]). The reason for the VARP:Rab32 interaction remains unclear. As it is not required for VARP recruitment to endosomal membranes, we did not pursue it further in this study. However, our data are consistent with a model in which VARP is initially recruited to the endosome through its interaction with retromer. Subsequently, the VARP:retromer complex may either be partitioned into or contribute to the formation of a Rab32-defined endosomal subdomain, from which trafficking out of the endosome may occur.

VAMP7 mediates fusion of both endosomes and endolysosomes with lysosomes and fusion of endolysosomes and their derived carriers with the plasma membrane (reviewed in [@bib9]). VAMP7 is then returned to its steady-state endolysosomal location through interactions with Hrb and AP-3 ([@bib4; @bib8; @bib28; @bib34; @bib45; @bib46; @bib47]). The demonstration that VARP can interact simultaneously with retromer and VAMP7 suggests other potential reasons why the VARP:retromer interaction may be important in trafficking out of endosomes. While Hrb and AP-3 appear to be the major factors determining the endosomal localization of VAMP7 (see [@bib28]), a role for VARP in VAMP7 distribution within the endosomal compartment is supported by our observation that a VARP binding-deficient mutant of VAMP7 is mislocalized away from endosomes in a similar manner to that observed in retromer-knockdown cells. The redistribution of VAMP7 to a TGN localization after loss of VARP interaction suggests that VARP:retromer is necessary to direct VAMP7 away from a retromer-independent endosome-to-Golgi retrieval pathway such as that used by furin ([@bib11]). Alternatively, VAMP7 redistribution to the TGN could be caused, at least in part, by VARP operating at the TGN to sort VAMP7 into vesicles for transport to endosomes ([@bib7]). However, this is difficult to reconcile with the inability to detect obvious localization of WT VARP at the TGN in nonneuronal cells by IF ([@bib67]) or immunoelectron microscopy ([@bib50]).

The incorporation of VAMP7 into retromer-dependent endosome-derived carriers could facilitate the subsequent fusion of these carriers with their final destinations (see also [@bib7]), consistent with our observation that both VAMP7 and retromer are required for delivery of the glucose transporter GLUT1 to the plasma membrane. In addition, once VARP is concentrated on an endosomal membrane by retromer, VARP has the potential to regulate the fusogenic ability of VAMP7 ([@bib50]). Therefore, it is possible that control of endosome/lysosome fusion could, in part, be regulated by the amount of retromer on the endosome surface through its ability to recruit VARP.

In summary, through its multiple interactions, VARP can link the retromer complex (VPS26/35/29) and its associated proteins (including sorting nexins and the WASH complex) to both a key ancestral R-SNARE protein (VAMP7) ([@bib18]) involved in many membrane fusion events ([@bib9]) and to an endosome-localized Rab ([Figure 7](#fig7){ref-type="fig"}). Thus, we propose that VARP is a key component of a protein network that both drives and controls traffic out of endosomes.

Experimental Procedures {#sec4}
=======================

Protein Expression and Purification {#sec4.1}
-----------------------------------

Protein expression was performed in *E. coli* Rosetta 2 pLysS. Cells were grown at 37°C, and expression was induced by the addition of 500 μM IPTG. VARP expression was carried out at 16°C for 20--24 hr, while all other proteins were expressed at 22°C for 14--18 hr. Cells were lysed in 20 mM HEPES, pH 7.4, and 500 mM NaCl (buffer A), supplemented with 5 mM MgCl~2~, 1 mM MnCl~2~, 5 mM dithiothreitol (DTT), 4 μg/ml DNase, and protease inhibitors and AEBSF. Seleno-methionine proteins were expressed in *E. coli* B834 using M9 media supplemented as in [@bib14].

Protein Purification and VARP:Rab Complex Reconstitution {#sec4.2}
--------------------------------------------------------

Proteins were first purified on GSH-sepharose, and the GST tag was cleaved off by incubating the beads with PreScission Protease (GE Healthcare) overnight at 4°C. His-tagged VARP~451--640~*His*~*6*~ was further purified on Ni-NTA agarose. All proteins were purified by gel filtration on Superdex 75 in buffer A supplemented with 10 mM DTT and additionally with 5 mM MgCl~2~ and 10 μM GppCp or GTPγS in the case of Rab32/38. Complexes were formed by mixing VARP with a GTPase in a molar excess of 1:1.25 for 1 hr at 4°C and finally subjecting them to gel filtration on Superdex 75 equilibrated in buffer A containing 5 mM MgCl~2~, 10 μM GppCp or GTPγS, and 10 mM DTT. Fractions of 1:1 complex as assessed by SDS-PAGE were pooled and concentrated for crystallization. Proteins for ITC were gel filtered on Superdex 75 in 50 mM HEPES, pH 7.4, 200 mM NaCl, 5 mM MgCl~2~, 1 mM TCEP.

Protein Purification for Pull-Downs {#sec4.3}
-----------------------------------

VARP~1--1050~His~10~ WT and mutants were purified in 500 mM NaCl, 20mM Tris pH8.5, (buffer B) as in ([@bib50]). GST-tagged proteins were purified on GSH-sepharose and eluted in buffer B containing 30 mM reduced glutathione, or the GST was removed by overnight incubation with PreScission Protease or thrombin as appropriate. Proteins were finally purified by gel filtration on Superdex 200 in buffer B that, in the case of Rabs, was supplemented with 5 mM MgCl~2~ and 10 μM of matching nucleotide.

Crystallization and Structure Determination {#sec4.4}
-------------------------------------------

Crystals of VARP~451--640~His~6~: Rab32~1--225~(Q85L) were grown by sitting drop vapor diffusion at 18°C against well solutions containing 14%--19% (w/v) of polyethylene glycol 3350 and 200 mM sodium citrate, pH 8.0, at an initial complex concentration of 2.5 mg/ml. Cryoprotected crystals exhibited anisotropic diffraction at 100 K and diffracted in the best directions to 2.8 Å. The structure was solved by molecular replacement with Phaser ([@bib35]), using models based on the structures of Rab7 (Protein Data Bank \[PDB\] ID [1YHN](pdb:1YHN){#intref0010}) and the VARP-ANKR domain 2 structure (PDB ID [4B93](pdb:4B93){#intref0015}). Crystals of VARP-ANKR domain 1:SeMet- Rab32~1--225~(Q85L/V100M/Q153M/V158M/I192M) and of VARP-ANKR domain 1:SeMet-Rab38 (Q69L) diffracted in their best directions to 3 Å and 4.5 Å, respectively. Their structures were solved by molecular replacement using the coordinates of native VARP-ANKR domain 1:Rab32Q85L complex as the search model. For a full description of structure determination, see [Supplemental Information](#app3){ref-type="sec"}.

Protein:Protein Interaction Studies {#sec4.5}
-----------------------------------

Y2H for screening and analyzing specific interactions was performed using pGBT9 and pGAD-C vectors and the HF7c reporter strain as previously described ([@bib24; @bib28; @bib46]). Growth on plates lacking histidine indicates that interaction occurred. For GST pull-down assays, 25--50 μg of the GST bait protein was incubated with 300 μg prey protein and 30--60 μl of a 50% (v/v) GSH-sepharose slurry in a total volume of 500 μl (5 mM MgCl~2~, 0.5mM TCEP, and 100 μM of the matching nucleotide was included if a Rab was present and 0.5mM ZnCl~2~ if a Cys-rich motif was present). The reactions were incubated for 1 hr at 4°C, and the beads were washed four times with 1 ml of buffer supplemented with 1% (w/v) NP40. Proteins were eluted from the beads using buffer containing 50 mM reduced GSH. Samples were analyzed on SDS-PAGE and/or western blots, which were probed with HisProbe-horseradish peroxidase conjugate or appropriate antibodies.

Isothermal Titration Calorimetry {#sec4.6}
--------------------------------

Experiments were performed using a Nano ITC from TA Instruments. VARP constructs at 60 μM were placed in the cell at 4°C, and Rab constructs at 300 μM were titrated with 24 injections of 2 μl with injections separated by 5 min. A minimum of three independent runs that showed clear saturation of binding were used to calculate the mean K~D~ of the binding reaction, its stoichiometry, and their corresponding SD values. Analysis of results and final figures were carried out using the NanoAnalyze Software.

microPIXE {#sec4.7}
---------

Samples were gel filtered at 10 mg/ml into 20 mM Tris, pH 7.4, 100 mM NaBr, and 0.5 mM TCEP to ensure low chlorine content and no nonprotein sulfur. The resulting spectra of X-rays were sorted into two-dimensional elemental maps from which the stoichiometric ratios of sulfur to other elements of interest were obtained.

Immunoprecipitation and Mass Spectrometry {#sec4.8}
-----------------------------------------

HeLaM cells stably expressing VPS29-EGFP or EGFP-VPS35 were lysed using PBS containing 1% Triton X-100. Following lysis, the samples were cleared by centrifugation at 10,000 × g for 5 min. The supernatant was transferred to a fresh tube and treated with protein-A sepharose (50 μl of a 25% slurry) for 30 min at 4°C on a rotating wheel. The lysates were then cleared again by centrifugation before being treated with a polyclonal anti-GFP antibody followed by protein-A sepharose essentially as described in [@bib24]. Following washes, proteins bound to protein-A sepharose were eluted using 200 mM glycine-HCl, pH 2.3, and then precipitated with ice-cold acetone. The precipitated proteins were digested with trypsin in solution and analyzed with an LTQ-OrbiTrap XL (Thermo) mass spectrometer essentially as described elsewhere ([@bib66]). For mass spectrometric analysis, four dishes (140 mm in diameter) of cells were used for each cell line. For western blotting analysis, a single dish of cells was used for each cell line, and the washed protein-A sepharose was dessicated in a SpeedVac prior to resuspension in SDS-PAGE sample buffer omitting the glycine elution and acetone precipitation steps.

Mammalian Cell Culture, Microscopy, and Western Blotting {#sec4.9}
--------------------------------------------------------

HeLaM cell populations stably expressing VARP-GFP constructs were generated using the pLXIN retroviral system (Clontech). When indicated, HeLaM cytosol was extracted prior to fixation by rinsing cells briefly with PBS, followed by incubation for 1 min in PBS (with Ca^2+^ and Mg^2+^) containing 0.05% saponin, and then immediately formaldehyde fixed. IF confocal microscopy and western blotting were carried out essentially as described elsewhere ([@bib50]). For quantitative IF confocal microscopy of GLUT1 and LAMP1 colocalization, cell fields (three independent experiments with five fields each per condition, average of ≥8 cells per field) were randomly selected based on nuclear stain and focused using the LAMP1 signal. Single confocal images were acquired corresponding to 1 Airy unit, and the degree of colocalization of two channels was measured by Manders M~1~/M~2~ colocalization coefficients ([@bib33]) using Zen software (Carl Zeiss). To negate the effects of inherent cell-to-cell variability of GLUT1 surface staining, the fraction of LAMP1 signal colocalizing with GLUT1 was measured for each field.

Author Contributions {#sec5}
====================
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![Structure of the VARP-ANKRD1:Rab32 Complex\
(A) Schematic representation of VARP and Rab32 proteins, highlighting the functions of different domains. The domain color scheme depicted is used in all subsequent figures.\
(B) Structure of the VARP (residues 451--640): Rab32(Q85L) heterodimer in "ribbon representation," with GppCp shown as ball and stick.\
(C) Orthogonal views of a VARP:Rab32 2:2 cross-dimer formed from two heterodimers that are in different asymmetric units. In the left-hand view, the membrane is located at the bottom, and in the right-hand view, the tetramer is viewed "through the membrane."\
(D and E) Surface representation, in (D), of the cross-dimer "opened out" as indicated to show the residues involved in the two different VARP:Rab32 interactions. The main residues involved are labeled in the zoomed-in views (bottom panels) and are shown highlighted in the same colors in the sequence alignment shown in (E).\
See also [Figure S1](#app3){ref-type="sec"}.](gr1){#fig1}

![Biochemical Analysis and In Vivo Role of the VARP:Rab32 Interaction\
(A) Molecular details of the VARP:Rab32 heterodimer interface. Residues mutated in VARP are boxed in color.\
(B) Effects on the binding of the VARP:Rab32 interaction of mutating key VARP residues in the interface as measured by ITC. Curves are color coded as in (A).\
(C) GST pull-downs using GSTRab32(Q85L) and VARP451-640His~6~ showing the effect of mutating key residues on VARP in the interaction interface (A).\
(D) Molecular details of VARP:Rab32 interface in orthogonal view to (A). Residues mutated in Rab32 are boxed in color.\
(E) Effects on the VARP:Rab32 interaction of mutating key Rab32 residues in the interface as measured by ITC. Curves are color coded as in (D).\
(F) GST pull-downs using GSTRab32(Q85L) and VARP451-640His~6~ showing the effect of mutating key residues on Rab32 in the interaction interface (D).\
(G) IF confocal microscopy of cytosol-extracted HeLa cells stably expressing VARP-GFP constructs: WT, Q509A/Y550A (QY), L513D/K546D (LK), M684D/Y687S (MY), and Q509A/Y550A/M684D/Y687S (QY+MY). GFP, green; VPS26, red; nuclei, blue, merged panel (MERGE). Boxed regions in the merged panels are shown as separate green (top), red (middle), and merged (bottom) channels on the right. Colocalization coefficients for the VPS26 versus GFP signals were as follows: WT, 0.89; QY, 0.75; LK, 0.59; MY, 0.66; QY+MY, 0.64. Scale bar, 20 μm.\
In (B) and (E), curves for data showing binding are the mean of a minimum of three experiments ± SD. In (C) and (F), top panels are gel stained with Coomassie blue, and the lower panels are western blots using an anti-His probe. See also [Figure S2](#app3){ref-type="sec"}.](gr2){#fig2}

![Retromer Recruits VARP on to Endosomes\
(A) IF confocal microscopy of cytosol-extracted HeLa cells stably expressing VARP-GFP, which were knocked down using single siRNA oligonucleotides at 100 nM (NT, nontargeting control, VPS29-1, VPS35-1, VAMP7-1, Rab32-1). GFP, green; EEA1, red; nuclei, blue, merged panel (MERGE).\
(B) Western blots of the cells imaged in (A) showing successful protein depletion.\
(C) IF confocal microscopy of VARP-GFP cells. GFP, green; and either VPS26, Fam21, or EEA1, red; nuclei, blue, merged panels. Cells were either fixed intact (whole cell) or after cytosol extraction (saponin). Boxed regions in the merged panels are shown as separate green (top), red (middle), and merged (bottom) channels on the right. Colocalization coefficients for VPS26, FAM21, and EEA1 versus GFP were as follows, respectively (saponin only): VPS26, 0.56; FAM21, 0.16; EEA1, 0.67.\
(D) IF confocal microscopy image of VARP-GFP cells. GFP, green; VPS26, red; the boxed regions (shown in the MERGE column) are enlarged below each image, demonstrating colocalization of VARP-GFP and VPS26 on both vacuolar and tubular domains of endosomes.\
Scale bars, 20 μm. See also [Figure S3](#app3){ref-type="sec"}.](gr3){#fig3}

![VARP Binds to a Conserved Hydrophobic Patch on VPS29\
(A) Y2H analysis using the activation domain (AD) fused to VARP and the DNA binding domain (BD) fused to the indicated retromer subunits. Strains were grown in the absence (−) or presence (+) of histidine.\
(B) Coomassie-stained gel of GST pull-down experiment showing the interaction of VARP-His~10~ (input, left lane) with GST alone, GST-VPS35 + VPS26 + VPS29 (GST-retromer), GST-VPS35 + VPS26 (GST-VPS35/VPS26), and GST-VPS29.\
(C) Coomassie-stained gel of GST pull-down experiment showing the interaction of VARP-His~10~ (input, left lane) with GST alone, GST-VPS29 WT, and L25D, I91S, and L152E mutants.\
(D) IF confocal microscopy of cytosol-extracted VARP-GFP cells knocked down using single siRNA oligonucleotides at 100 nM (NT, nontargeting control, VPS29-1). Twenty-four hours prior to fixation, cells were transiently transfected with VPS29-tRFP WT or L152E mutant. MERGE, merged panels.\
(E) IF confocal microscopy of cytosol-extracted HeLa cells following knockdown with 100 nM VPS29-1 siRNA oligonucleotide performed as in (D). Twenty-four hours prior to fixation, cells were transiently transfected with VPS29-tRFP WT or L152E mutant (TBC1D5 \[green\], FAM21 \[magenta\], VPS29-tRFP imaged by native fluorescence, and nuclei \[blue, merged panels\]). Scale bars, 20 μm.\
See also [Figure S4](#app3){ref-type="sec"}.](gr4){#fig4}

![VARP Binds to VPS29 via Two Conserved Zn^2+^ Coordinating Cys-Rich Motifs\
(A) The two conserved Cys-rich motifs (conserved residues highlighted in pink with asterisks beneath them) in VARP from different species. Residue numbering is given for the human sequence.\
(B) Proton-induced X-ray emission (PIXE) spectra for protein fragments containing the first (residues 396--460, left) and second (residues 692--746, right) Cys-rich motifs, with the Zn and Br peaks labeled above them. Black dots indicate the individual data points, and the red line is the fit.\
(C--E) In (C), Y2H analysis is shown of the DNA binding domain (BD) fused to VPS29 and the activation domain (AD) fused to the indicated VARP fragments. Mutations within the Cys-rich motifs are labeled as follows in (C), (D), and (E): (first motif) H432A/L434A = HL1, C431S/C435S/C437S/C440S = 4C1; (second motif) H712A/L714A = HL2, C711S/C715S/C717S/C720S = 4C2. (D) Coomassie-stained gel of GST pull-down experiment showing interaction of VARP-His~10~ WT or the indicated VARP mutants with GST-VPS29 or with GST alone. (E) IF confocal microscopy of cytosol extracted HeLa cells stably expressing VARP-GFP WT or the indicated VARP mutants. GFP, green; VPS26, red; nuclei, blue, merged panels (MERGE). Colocalization coefficients of VPS26 versus GFP were as follows: WT, 0.9; HL1, 0.08; 4C1, 0.09; HL2, 0.07; 4C2, 0.1; HL1+HL2, 0; 4C1+ 4C2, 0. Scale bar, 20 μm.\
(F) GST pull-down experiment showing the interaction of the indicated combinations of VARP-His~10~, Rab32, and VAMP7 cytoplasmic domain (CD) (inputs, left three lanes), with either GST alone or GST-VPS29. The pull-down samples were western blotted for Rab32 and VAMP7.\
See also [Figure S5](#app3){ref-type="sec"}.](gr5){#fig5}

![The VARP/Retromer/VAMP7 Protein Network Is Required for GLUT1 Trafficking between Endosomes and the Cell Surface\
(A) HeLa cells knocked down with single siRNA oligonucleotides at 100 nM (NT, nontargeting control). AP-1 γ and μ1 subunits were knocked down simultaneously (pool of four individual oligonucleotides at 20 nM for each subunit). Cells were imaged by IF confocal microscopy, and the fraction of cells with GLUT1 redistributed from the cell surface to an intracellular endosomal localization with the indicated knockdown was graphed (mean ± SEM of three independent experiments with \>400 cells scored for each condition, ^∗^p \< 0.05).\
(B and C) HeLa cells were knocked down as shown in (A), and cells were imaged by IF confocal microscopy. LAMP1, green; GLUT1, red; nuclei, blue, merged panels (MERGE). Five independent fields of cells were imaged for each condition, and the colocalization coefficient measuring the colocalization of GLUT1 with LAMP1 was obtained for each field. The graph in (B) is a representative experiment (mean ± SEM of five fields), with representative IF confocal images shown in (C).\
(D and E) HeLa cells were knocked down as in (A) with either nontargeting control (NT) or VPS29-1 oligonucleotides. Twenty-four hours prior to fixation, cells were transfected with siRNA-resistant VPS29-tRFP WT (resWT) or L152E mutant (resL152E). Cells were imaged by IF confocal microscopy. tRFP, red; LAMP1, blue; GLUT1, green; nuclei, white, merged panels (MERGE). Individual VPS29-tRFP-expressing cells (≥17 cells per condition) were identified, and the colocalization coefficient measuring the colocalization of GLUT1 with LAMP1 was obtained for each cell. Colocalization coefficients from three independent experiments are shown in (D) (mean ± SEM, ^∗^p \< 0.05, ^∗∗^p \< 0.01, NS, not significant, using a two-tailed unpaired t test), and representative cell images are shown in (E). Cells analyzed in the VP29-1 knockdown-only condition were cells not transfected by VPS29-tRFP within VPS29-1 + resL152E experiments.\
Scale bars, 20 μm. See also [Figure S6](#app3){ref-type="sec"}.](gr6){#fig6}

![The Steady-State Localization of VAMP7 Depends on Its Interaction with VARP\
(A and B) HeLa cells stably expressing VAMP7-HA WT or DES were imaged by IF confocal microscopy: HA, green; TGN46, red; nuclei, blue, merged panels (MERGE). Cells were either left untreated or treated with 100 μM CQ for 2 hr prior to fixation. Seven independent fields (≥10 cells per field) were imaged for each condition, and the colocalization coefficient measuring the colocalization of VAMP7-HA with TGN46 was obtained for each field \[mean ± SEM in (B) with representative cell images in (A)\].\
(C) IF confocal microscopy of VAMP7-HA HeLa cells knocked down with the indicated siRNA oligonucleotides at 100 nM (NT, nontargeting control, VPS29-1, VPS35-1): HA, green; TGN46, red; nuclei, blue, merged panels. Scale bars, 20 μm.\
(D) Fifteen independent fields (≥10 cells per field) were imaged for each condition, and the colocalization coefficient measuring the colocalization of VAMP7-HA with TGN46 was obtained for each field (mean ± SEM). Data shown are representative of three independent experiments. NT, nontargeting control.\
(E) Model of the VARP/retromer/VAMP7 protein network.\
VAMP7 is endocytosed from the plasma membrane as a cis-SNARE complex through the action of Hrb/AP-2 and is subsequently delivered to a late endosomal compartment through the action of AP-3. VARP is recruited to endosomal membranes by the retromer complex through its direct interaction with VPS29, thus allowing VARP to bind to free VAMP7 on the surface of endosomes.](gr7){#fig7}

###### 

Crystallographic Data for VARP ANKRD1:Rab32(Q85L) Crystals

  Parameter                                               Native                           Xenon
  ------------------------------------------------------- -------------------------------- --------------------------------
  Space group                                             P3~2~21                          P3~2~21
  Number of complexes in ASU                              3                                3
  Unit cell (Å)                                           *a* = *b* = 144.4, *c* = 135.7   *a* = *b* = 144.9, *c* = 137.0
  Wavelength (Å)                                          0.9763                           1.7
  Resolution range (Å)                                    72.22--2.80 (2.91--2.80)         72.45--3.30 (3.53--3.30)
  Beamline                                                I03                              I03
  Number of crystals                                      3                                1
  R~merge~                                                0.237 (2.215)                    0.318 (2.091)
  R~merge~ in top intensity bin                           0.070                            0.057
  R~meas~                                                 0.256 (2.460)                    0.328 (2.153)
  R~pim~                                                  0.093 (1.042)                    0.077 (0.508)
  Number of total reflections                             295,603 (21,370)                 437,743 (78,174)
  Number of unique reflections                            40,077 (4,267)                   25,238 (4,491)
  Mean (\[I\]/SD\[I\])                                    8.8 (0.9)                        9.8 (2.3)
  Half-data set correlation coefficient CC~1/2~           0.989 (0.229)                    0.996 (0.663)
  Completeness (%)                                        98.8 (94.1)                      99.4 (98.9)
  Anomalous completeness (%)                                                               99.6 (99.1)
  Multiplicity                                            7.4 (5.0)                        17.3 (17.4)
  Anomalous multiplicity                                                                   9.0 (8.9)
  Δ~anom~ Correlation between half-sets                                                    0.146 (inner 0.763)
  Wilson plot B (Å^2^)[a](#tblfn1){ref-type="table-fn"}   54.1                             79.3
                                                                                           
  **Refinement**                                                                           
                                                                                           
   Number of atoms                                                                         
   Protein                                                8,040                            
   Ligand                                                 99                               
   Xe                                                                                      9
   H~2~O                                                  145                              
   R-factor                                               0.19                             
   R~free~                                                0.24                             
   Number of reflections (number R~free~)                 38,004 (2,011)                   
   \<B \> (Å^2^)                                          74.2                             
   rms bond length deviation (Å)                          0.011                            
   rmsd angle deviation (°)                               1.589                            
   Ramachandran favored (%)                               92.8                             
   Ramachandran outliers (%)                              1.6                              

R~merge~ = Σ(I~hl~ − \< I~h~ \>)/Σ \< I~h~ \>.

R~meas~ = Σ√(n~h~/n~h~ − 1)(I~hl~ − \< I~h~ \>)/Σ \< I~h~ \>.

R~pim~ = Σ√(1/n~h~ − 1)(I~hl~ − \< I~h~ \>)/Σ \< I~h~ \>.

ASU, asymmetric units.

"Inner" resolution range, 72.45--9.33 Å.
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